Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs...
Ingrid Haugen
Health Net Federal Services, LLC (HNFS), a Centene Corporation (NYSE: CNC) subsidiary, announced its renewed Utilization Review Accreditation Commission (URAC) accreditations in Health...
Stuart Therapeutics, Inc. (“Stuart”), a clinical stage biopharmaceutical company conducting research and development of unique extracellular matrix-targeting...
Calliditas Therapeutics AB (Nasdaq: CALT) and (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the company has signed and fully drawn...
LANGaware, an innovative digital assessment tool, is excited to announce its transformative collaboration with BThere Healthcare, a...
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“WELL” or the “Company”), a digital health company focused on...
Genetic information collected from seemingly healthy tissue near lung tumors may be a better predictor of whether...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx Pharmaceuticals”, (NRx), a clinical-stage biopharmaceutical company and Nephron Pharmaceuticals, Inc. (Nephron), a...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine ER) for difficult...
As the public is paying increasing attention to health management, the 5-day onsite exhibition of Phase 3...